Study to Evaluate Safety, Tolerability, and Pharmacokinetics of XNW4107 Alone or in Combination With Imipenem/Cilastatin
Clinical trial NCT04482569 · COMPLETED
Trial details
- NCT number
- NCT04482569
- Sponsor
- Evopoint Biosciences Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-10
- Primary completion
- 2021-02-28
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.